These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16965636)

  • 1. Discovery and validation of breast cancer subtypes.
    Kapp AV; Jeffrey SS; Langerød A; Børresen-Dale AL; Han W; Noh DY; Bukholm IR; Nicolau M; Brown PO; Tibshirani R
    BMC Genomics; 2006 Sep; 7():231. PubMed ID: 16965636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer molecular profiling with single sample predictors: a retrospective analysis.
    Weigelt B; Mackay A; A'hern R; Natrajan R; Tan DS; Dowsett M; Ashworth A; Reis-Filho JS
    Lancet Oncol; 2010 Apr; 11(4):339-49. PubMed ID: 20181526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
    Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
    Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of genes and pathways involved in breast cancer subtypes through gene expression meta-analysis.
    Jafarinejad-Farsangi S; Moazzam-Jazi M; Naderi Ghale-Noie Z; Askari N; Miri Karam Z; Mollazadeh S; Hadizadeh M
    Gene; 2022 May; 821():146328. PubMed ID: 35181505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Protein Translation and Extracellular Matrix Gene Sets with Breast Cancer Metastasis: Findings Uncovered on Analysis of Multiple Publicly Available Datasets Using Individual Patient Data Approach.
    Chowdhury N; Sapru S
    PLoS One; 2015; 10(6):e0129610. PubMed ID: 26080057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
    Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
    PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular portraits of breast tumors are conserved across microarray platforms.
    Hu Z; Fan C; Oh DS; Marron JS; He X; Qaqish BF; Livasy C; Carey LA; Reynolds E; Dressler L; Nobel A; Parker J; Ewend MG; Sawyer LR; Wu J; Liu Y; Nanda R; Tretiakova M; Ruiz Orrico A; Dreher D; Palazzo JP; Perreard L; Nelson E; Mone M; Hansen H; Mullins M; Quackenbush JF; Ellis MJ; Olopade OI; Bernard PS; Perou CM
    BMC Genomics; 2006 Apr; 7():96. PubMed ID: 16643655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
    Rouzier R; Perou CM; Symmans WF; Ibrahim N; Cristofanilli M; Anderson K; Hess KR; Stec J; Ayers M; Wagner P; Morandi P; Fan C; Rabiul I; Ross JS; Hortobagyi GN; Pusztai L
    Clin Cancer Res; 2005 Aug; 11(16):5678-85. PubMed ID: 16115903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
    Gong Y; Yan K; Lin F; Anderson K; Sotiriou C; Andre F; Holmes FA; Valero V; Booser D; Pippen JE; Vukelja S; Gomez H; Mejia J; Barajas LJ; Hess KR; Sneige N; Hortobagyi GN; Pusztai L; Symmans WF
    Lancet Oncol; 2007 Mar; 8(3):203-11. PubMed ID: 17329190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.
    Callari M; Musella V; Di Buduo E; Sensi M; Miodini P; Dugo M; Orlandi R; Agresti R; Paolini B; Carcangiu ML; Cappelletti V; Daidone MG
    Mol Oncol; 2014 Oct; 8(7):1278-89. PubMed ID: 24853384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated observation of breast tumor subtypes in independent gene expression data sets.
    Sorlie T; Tibshirani R; Parker J; Hastie T; Marron JS; Nobel A; Deng S; Johnsen H; Pesich R; Geisler S; Demeter J; Perou CM; Lønning PE; Brown PO; Børresen-Dale AL; Botstein D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8418-23. PubMed ID: 12829800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.
    Al-Mulla F; Marafie M; Zea Tan T; Paul Thiery J
    J Cell Biochem; 2014 Mar; 115(3):488-97. PubMed ID: 24123286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
    Sørlie T; Perou CM; Tibshirani R; Aas T; Geisler S; Johnsen H; Hastie T; Eisen MB; van de Rijn M; Jeffrey SS; Thorsen T; Quist H; Matese JC; Brown PO; Botstein D; Lønning PE; Børresen-Dale AL
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10869-74. PubMed ID: 11553815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of molecular subtypes of Korean breast cancer: an ethnically and clinically distinct population.
    Han W; Nicolau M; Noh DY; Jeffrey SS
    Int J Oncol; 2010 Jul; 37(1):51-9. PubMed ID: 20514396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Wilms' tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer.
    Qi XW; Zhang F; Yang XH; Fan LJ; Zhang Y; Liang Y; Ren L; Zhong L; Chen QQ; Zhang KY; Zang WD; Wang LS; Zhang Y; Jiang J
    Oncol Rep; 2012 Oct; 28(4):1231-6. PubMed ID: 22797561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.
    Calza S; Hall P; Auer G; Bjöhle J; Klaar S; Kronenwett U; Liu ET; Miller L; Ploner A; Smeds J; Bergh J; Pawitan Y
    Breast Cancer Res; 2006; 8(4):R34. PubMed ID: 16846532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.